Drospirenone+ Ethinyl Estradiol Tablets-Reference product

DRUG2 trials

Sponsors

Bio-innova Co., Ltd

Conditions

Healthy Subjects

Phase 1

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Not yet recruitingNCT06233058

Bio-innova Co., LtdHealthy Subjects

Start: 2024-03-05End: 2024-05-27Target: 32Updated: 2024-01-31

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

RecruitingNCT06233071

Bio-innova Co., LtdHealthy Subjects

Start: 2024-02-13End: 2024-05-02Target: 32Updated: 2024-03-12